INTELLIGENTLY FORMULATED WITH

AEROSPHERE™ Delivery Technology

BEVESPI Inhaler
BEVESPI Inhaler

All images are for illustrative purposes only.

Intelligent formulation
for a pMDI* using patented,
phospholipid-based
AEROSPHERE™ DELIVERY TECHNOLOGY1


Reaches
LARGE AND SMALL airways2†

All images are for illustrative purposes only.

*BEVESPI AEROSPHERE is a pMDI containing the LAMA glycopyrrolate and LABA formoterol fumarate, along with phospholipid porous particles that form the co-suspension with the micronized drug crystals.

As defined by mass median aerodynamic diameter (MMAD), changes in inspiratory capacity, and changes in specific image-based airway resistance for BEVESPI AEROSPHERE.

There is no proven correlation between AEROSPHERETM Delivery Technology and efficacy or safety.